PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 121 filers reported holding PTC THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,087,000 | -44.5% | 55,935 | -40.8% | 0.00% | -50.0% |
Q4 2021 | $3,760,000 | +16.3% | 94,410 | +8.7% | 0.00% | 0.0% |
Q3 2021 | $3,232,000 | +6.3% | 86,862 | +20.7% | 0.00% | 0.0% |
Q2 2021 | $3,041,000 | +0.7% | 71,948 | +12.8% | 0.00% | 0.0% |
Q1 2021 | $3,020,000 | -9.6% | 63,771 | +16.5% | 0.00% | 0.0% |
Q4 2020 | $3,340,000 | +43.9% | 54,728 | +10.2% | 0.00% | 0.0% |
Q3 2020 | $2,321,000 | +3.6% | 49,641 | +12.4% | 0.00% | 0.0% |
Q2 2020 | $2,241,000 | +10.8% | 44,161 | -2.6% | 0.00% | 0.0% |
Q1 2020 | $2,023,000 | +9.7% | 45,343 | +18.1% | 0.00% | +100.0% |
Q4 2019 | $1,844,000 | +46.1% | 38,394 | +2.9% | 0.00% | 0.0% |
Q3 2019 | $1,262,000 | -16.8% | 37,328 | +10.7% | 0.00% | 0.0% |
Q2 2019 | $1,517,000 | -2.9% | 33,708 | -18.8% | 0.00% | 0.0% |
Q1 2019 | $1,563,000 | +7.3% | 41,522 | -2.1% | 0.00% | 0.0% |
Q4 2018 | $1,456,000 | +17.4% | 42,420 | +60.7% | 0.00% | 0.0% |
Q3 2018 | $1,240,000 | +32.3% | 26,391 | -5.0% | 0.00% | 0.0% |
Q2 2018 | $937,000 | +28.0% | 27,789 | +2.7% | 0.00% | 0.0% |
Q1 2018 | $732,000 | +61.9% | 27,069 | -0.2% | 0.00% | – |
Q4 2017 | $452,000 | -15.5% | 27,120 | +1.4% | 0.00% | -100.0% |
Q3 2017 | $535,000 | -39.2% | 26,739 | -44.3% | 0.00% | 0.0% |
Q2 2017 | $880,000 | +122.2% | 48,004 | +19.4% | 0.00% | 0.0% |
Q1 2017 | $396,000 | -56.1% | 40,216 | -51.4% | 0.00% | 0.0% |
Q4 2016 | $902,000 | +47.4% | 82,673 | +89.3% | 0.00% | 0.0% |
Q3 2016 | $612,000 | +64.1% | 43,677 | -17.9% | 0.00% | 0.0% |
Q2 2016 | $373,000 | +203.3% | 53,184 | +178.9% | 0.00% | – |
Q1 2016 | $123,000 | -98.1% | 19,072 | -90.3% | 0.00% | -100.0% |
Q4 2015 | $6,380,000 | +1186.3% | 196,918 | +960.5% | 0.01% | +1000.0% |
Q3 2015 | $496,000 | -29.7% | 18,569 | +26.6% | 0.00% | 0.0% |
Q2 2015 | $706,000 | -6.7% | 14,665 | +17.9% | 0.00% | -50.0% |
Q1 2015 | $757,000 | +23.3% | 12,439 | +4.9% | 0.00% | +100.0% |
Q4 2014 | $614,000 | +27.4% | 11,860 | +8.3% | 0.00% | 0.0% |
Q3 2014 | $482,000 | – | 10,955 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |